Company Overview

Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, prescription drugs, and processed foods in Japan and internationally. The company operates through four segments: Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. It offers tobacco products, such as cigarettes, cigars, pipe tobacco, oral tobacco, waterpipe tobacco, kretek, and fine cut products under the Winston, Camel, MEVIUS, and LD brands. The company also provides reduced-risk products, including tobacco-infused vapor and heated tobacco products, E-Vapor products, etc. under the Ploom, Logic, Ploom TECH, Ploom TECH+, and Ploom S brands. In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, renal and metabolism, immunology, and neuroscience. Further, the company provides staple food products, such as frozen noodles and okonomiyaki, and frozen and packed cooked rice; ambient processed foods; bakery products; and seasonings, including yeast extracts and oyster sauce. Japan Tobacco Inc. was founded in 1898 and is headquartered in Tokyo, Japan.

  • Name

    Japan Tobacco Inc.

  • CEO

    Mr. Masamichi Terabatake

  • Website

    www.jt.com

  • Sector

    Tobacco

  • Year Founded

    1985

Profile

  • Market Cap

    ¥7,409.38B

  • EV

    ¥7,580.59B

  • Shares Out

    1,775.55M

  • Revenue

    ¥3,018.16B

  • Employees

    53,239

Margins

  • Gross

    55.45%

  • EBITDA

    28.01%

  • Operating

    21.99%

  • Pre-Tax

    21.45%

  • Net

    16.58%

  • FCF

    16.84%

Returns (5Yr Avg)

  • ROA

    6.54%

  • ROTA

    14.2%

  • ROE

    12.54%

  • ROCE

    11.85%

  • ROIC

    8.11%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    ¥4,544.44

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    ¥1,087.84B

  • Net Debt

    ¥64.64B

  • Debt/Equity

    0.25

  • EBIT/Interest

    18.21

Growth (CAGR)

  • Rev 3Yr

    11%

  • Rev 5Yr

    6.54%

  • Rev 10Yr

  • Dil EPS 3Yr

    11.29%

  • Dil EPS 5Yr

    4.92%

  • Dil EPS 10Yr

  • Rev Fwd 2Yr

    4.81%

  • EBITDA Fwd 2Yr

    2.56%

  • EPS Fwd 2Yr

    4.59%

  • EPS LT Growth Est

    13.04%

Dividends

  • Yield

  • Payout

    69.89%

  • DPS

    ¥197

  • DPS Growth 3Yr

    11.53%

  • DPS Growth 5Yr

    5.32%

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

    5.84%

TSE:2914